title: Vancomycin continuous infusion as prophylaxis for vascular surgery.
abstract: Prosthetic graft infection is a devastating complication of vascular surgery that occurs in 3%-5% of clean prosthetic procedures. Staphylococci are the most frequently isolated pathogens, and thus surgical prophylaxis regimens often include vancomycin. However, the efficacy of these regimens in ensuring a required concentration of antibiotic is uncertain. This study aimed to determine if a continuous vancomycin infusion regimen administered perioperatively as surgical prophylaxis for vascular procedures maintained an adequate serum concentration. Thirty-four consecutive patients undergoing a vascular procedure requiring a prosthetic graft or patch were given vancomycin prophylaxis. Each patient received a loading dose calculated according to body weight 12 hours before surgery. A 24-hour continuous infusion was then started, based on calculated creatinine clearance. Serum vancomycin concentrations were checked on induction of anesthesia, 2 hours postoperatively, and at the end of the infusion. Perioperative fluid administration and blood loss were recorded. An estimated creatinine clearance was repeated on the second postoperative day. Of the 34 patients recruited, 7 did not have the anticipated procedure and 6 patients had incomplete sample collection. Twenty-one patients with complete sample collection were analyzed. The target concentration (10-25 mg/L) was achieved in 81% of all samples. All patients achieved the target concentration at 1 or more time points. The regimen employed provided appropriate concentrations at the time of intervention. No potentially toxic concentrations or adverse reactions to vancomycin were encountered. Vancomycin given as a continuous infusion delivers adequate serum concentration. Long-term graft infection rates are needed to show a clinical effect.
authors.affiliation: Department of Vascular and General Surgery, Gartnavel General Hospital, Glasgow, Scotland, United Kingdom. chrispayne@doctors.org.uk
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Payne
authors.forename: Samantha J
authors.initials: SJ
authors.lastname: Carmichael
authors.forename: Adam T
authors.initials: AT
authors.lastname: Stearns
authors.forename: David B
authors.initials: DB
authors.lastname: Kingsmore
authors.forename: Dominique S
authors.initials: DS
authors.lastname: Byrne
authors.forename: Alexander R
authors.initials: AR
authors.lastname: Binning
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000465:Algorithms; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D019917:Blood Vessel Prosthesis Implantation; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008485:Medical Audit; D008875:Middle Aged; D019990:Perioperative Care / Q000379:methods; D016459:Prosthesis-Related Infections / Q000517:prevention & control*; D013997:Time Factors; D016896:Treatment Outcome; D014640:Vancomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin